Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Operating activities:
Net income	$ 114,154	$ 9,683
Adjustments to net income:
Provision for (recovery of) bad debts	(117)	660
Deferred tax expense (benefit)	284	(36,002)
Depreciation and amortization	30,318	64,039
Amortization of developed technology	10,918	10,918
Amortization of debt discount and issuance costs	9,123	5,003
Equity-based compensation	11,695	11,677
Contingent consideration	2,232	(5,981)
Warranty provision	451	4,341
Write-down of inventories	4,587	(2,333)
Change in fair value of derivative assets	1,140	0
Changes in operating assets and liabilities, net of business acquisition:
Accounts receivable	(6,364)	(139,036)
Inventories	12,554	(14,273)
Income tax receivables	3,165	(3,610)
Prepaid expenses and other	(2,140)	16,329
Accounts payable	14,443	42,073
Accrued expenses and other	18,484	41,271
Warranty payments	0	(373)
Income tax payable	(738)	2,951
Lease liabilities	(8,050)	1,914
Deferred revenue	(78,165)	34,772
Net cash provided by operating activities	137,974	44,023
Investing activities:
Purchase of property, plant and equipment	(11,615)	(6,690)
Acquisition of STI, net of cash acquired	0	(373,816)
Net cash used in investing activities	(11,615)	(380,506)
Financing activities:
Proceeds from Series A issuance	0	33,098
Proceeds from common stock issuance	0	15,885
Series A equity issuance costs	(1,509)	(1,167)
Common stock issuance costs	0	(450)
Dividends on Series A Preferred	0	(18,670)
Payments on revolving credit facility	0	(116,000)
Proceeds from revolving credit facility	0	116,000
Proceeds from issuance of other debt	60,516	39,219
Principal payments on term loan facility	(73,225)	0
Principal payments on other debt	(69,024)	(33,286)
Contingent consideration payments	(1,200)	(1,483)
Net cash provided by (used in) financing activities	(84,442)	33,146
Effect of exchange rate changes on cash and cash equivalent balances	(1,808)	(1,555)
Net change in cash and cash equivalents	40,109	(304,892)
Cash and cash equivalents, beginning of period	133,901	367,670
Cash and cash equivalents, end of period	174,010	62,778
Supplemental Cash Flow Information
Cash paid for interest	36,136	22,226
Cash paid for income taxes (net of refunds)	36,797	1,189
Non-cash Investing and Financing Activities
Dividends accrued on Series A Preferred	19,567	0
Stock consideration paid for acquisition of STI	$ 0	$ 200,224